B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

PTGES

MOLECULAR TARGET

prostaglandin E synthase

UniProt: O14684NCBI Gene: 953618 compounds

PTGES (prostaglandin E synthase) is targeted by 18 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting PTGES

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1epigalocatechin gallate5.40220
2zileuton5.04154
3tilarginine4.73112
4ns 3984.2871
5zafirlukast3.8948
6embelin3.2625
7licofelone3.0420
8akba2.8917
911 keto boswellic acid2.8316
10boswellic acid2.6413
11atranorin2.309
12Celecoxib1.956
13salvin [Supplementary Concept]1.102
14carnosol1.102
15ns3981.102
16egcg0.691
17Indomethacin0.691
18bdb chembl30944240.691

About PTGES as a Drug Target

PTGES (prostaglandin E synthase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 18 compounds with documented PTGES interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

PTGES inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.